LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Hologic Inc

Fechado

SetorSaúde

64.32 2.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

64.2

Máximo

64.57

Indicadores-chave

By Trading Economics

Rendimento

-218M

-17M

Vendas

-17M

1B

P/E

Médio do Setor

26.055

51.198

EPS

1.03

Margem de lucro

-1.731

Funcionários

7,063

EBITDA

-359M

-7M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+3.3% upside

Dividendos

By Dow Jones

Próximos Ganhos

28 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.1B

14B

Abertura anterior

62.21

Fecho anterior

64.32

Sentimento de Notícias

By Acuity

24%

76%

56 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Hologic Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de mai. de 2025, 18:46 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

27 de mai. de 2025, 20:07 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 de mai. de 2025, 19:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 de mai. de 2025, 18:26 UTC

Aquisições, Fusões, Aquisições de Empresas

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Comparação entre Pares

Variação de preço

Hologic Inc Previsão

Preço-alvo

By TipRanks

3.3% parte superior

Previsão para 12 meses

Média 66.45 USD  3.3%

Máximo 71 USD

Mínimo 60 USD

Com base em 14 analistas de Wall Street que oferecem metas de preço de 12 meses para Hologic Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

14 ratings

5

Comprar

9

Manter

0

Vender

Pontuação Técnica

By Trading Central

52.69 / 58.605Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

56 / 380 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.